Try our beta test site
1 study found for:    lymphoma OR CLL | IMMU-114
Show Display Options
Rank Status Study
1 Recruiting Phase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLL
Conditions: Non-hodgkin's Lymphoma;   Follicular Lymphoma;   Mantle Cell Lymphoma;   Marginal Zone Lymphoma;   Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma
Intervention: Drug: IMMU-114

Study has passed its completion date and status has not been verified in more than two years.